4.5 Article

Inducible Degradation of Target Proteins through a Tractable Affinity-Directed Protein Missile System

Journal

CELL CHEMICAL BIOLOGY
Volume 27, Issue 9, Pages 1164-+

Publisher

CELL PRESS
DOI: 10.1016/j.chembiol.2020.06.013

Keywords

-

Funding

  1. UK Medical Research Council (MRC) [MC_UU_00018/6, MC_UU_12016/3]
  2. Division of Signal Transduction Therapy (Boehringer-Ingelheim)
  3. Division of Signal Transduction Therapy (GlaxoSmithKline)
  4. Division of Signal Transduction Therapy (Merck-Serono)
  5. UK MRC Prize PhD studentship
  6. European Research Council (ERC) under the European Union's Seventh Framework Program [ERC-2012-StG-311460]
  7. Boehringer Ingelheim
  8. Eisai Inc.
  9. Nurix Inc.
  10. Ono Pharma
  11. Amphista Therapeutics
  12. MRC [MC_UU_12016/3, MC_UU_00018/6] Funding Source: UKRI

Ask authors/readers for more resources

The affinity-directed protein missile (AdPROM) system utilizes specific polypeptide binders of intracellular proteins of interest (POIs) conjugated to an E3 ubiquitin ligase moiety to enable targeted proteolysis of the POI. However, a chemically tuneable AdPROM system is more desirable. Here, we use Halo-tagNHL-recruiting proteolysis-targeting chimera (HaloPROTAC) technology to develop a ligand-inducible AdPROM (L-Ad-PROM) system. When we express an L-AdPROM construct consisting of an anti-GFP nanobody conjugated to the Halo-tag, we achieve robust degradation of GFP-tagged POls only upon treatment of cells with the HaloPROTAC. For GFP-tagged POls, ULK1, FAM83D, and SGK3 were knocked in with a GFP-tag using CRISPR/ Cas9. By substituting the anti-GFP nanobody for a monobody that binds H- and K-RAS, we achieve robust degradation of unmodified endogenous RAS proteins only in the presence of the HaIoPROTAC. Through substitution of the polypeptide binder, the highly versatile L-AdPROM system is useful for the inducible degradation of potentially any intracellular POI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available